Cancer Immunotherapy

The war on cancer began a little more than 40 years ago as a national research program to radically improve the survival of patients with cancer, a leading cause of death in the United States and worldwide. The main weapons deployed have been surgery, radiation, and chemotherapy, treatments that often carry risks and/or cause adverse side effects. Although some forms of cancer yield to these therapies, not all do, and thus mortality remains high.